Articles dans des revues avec comité de lecture (41)
  1. 13. Hendlisz, A., Deleporte, A., Delaunoit, T., Marechal, R., Peeters, M., Holbrechts, S., Van Den Eynde, M., Houbiers, G., Filleul, B., Van Laethem, J.-L., Ceyssens, S., Barbuto, A.-M., Lhommel, R., Demolin, G., Garcia, C., El Mansy, H., Ameye, L., Moreau, M., Guiot, T., Paesmans, M., Piccart-Gebhart, M., Flamen, P., & Santini, D. (2015). The prognostic significance of metabolic response heterogeneity in metastatic colorectal cancer. PloS one, 10(9), e138341. doi:10.1371/journal.pone.0138341
  2. 14. Bouazza, F., Poncelet, A., Garcia, C., Delatte, P., Engelhom, J. L., Gomez-Galdon, M., Deleporte, A., Hendlisz, A., Vanderlinden, B., Flamen, P., & Donckier De Donceel, V. (2015). Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma. World Journal of Gastroenterology, 21(32), 9666-9670. doi:10.3748/wjg.v21.i32.9666
  3. 15. Hendlisz, A., Golfinopoulos, V., Deleporte, A., Mansy, H. E., Vandeputte, C., Maetens, M. M., Awada, A., Piccart-Gebhart, M., Paesmans, M., Garcia, C., Flamen, P., Peeters, M., Annemans, L., Van Den Eynde, M., Borbath, I., Dresse, D., Houbiers, G., Fried, M., Marechal, R., & Van Laethem, J.-L. (2015). Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study [BMC Cancer, 13, (2013), 190]. BMC cancer, 15(1), 173. doi:10.1186/s12885-015-1181-5
  4. 16. Hendlisz, A., Deleporte, A., Vandeputte, C., Charette, N., Paesmans, M., Guiot, T., Garcia, C., & Flamen, P. (2015). Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol. BMJ open, 5(3), e007189. doi:10.1136/bmjopen-2014-007189
  5. 17. Amzerin, M., Garcia, C., Stanciu, C., Veys, I., Awada, A., Errihani, H., & Gombos, A. (2014). Case Report: Mammary and rectal metastases from an ovarian cancer: Report of two cases and review of literature. F1000Research, 3. doi:10.12688/f1000research.2644.2
  6. 18. Garcia, C. (2014). Apport de l'imagerie médicale fonctionnelle dans le diagnostic du nodule pulmonaire. Revue des Maladies Respiratoires Actualites, 6(4), 363-372. doi:10.1016/S1877-1203(14)70590-7
  7. 19. Deleporte, A., Paesmans, M., Garcia, C., Vandeputte, C., Lemort, M., Engelholm, J. L., Hoerner, F., Aftimos, P., Awada, A., Charette, N., Machiels, G., Piccart-Gebhart, M., Flamen, P., & Hendlisz, A. (2014). Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: The CORIOLAN study. BMC cancer, 14(1), 385. doi:10.1186/1471-2407-14-385
  8. 20. Orlhac, F., Soussan, M., Buvat, I., Maisonobe, J.-A., Garcia, C., & Vanderlinden, B. (2014). Tumor texture analysis in 18F-FDG PET: Relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. The Journal of nuclear medicine, 55(3), 414-422. doi:10.2967/jnumed.113.129858
  9. 21. Berghmans, T., Cortot, A., CsToth, I., Garcia, C., Giner-Marco, V., Grigoriu, B. D., Holbrechts, S., Lafitte, J.-J., Meert, A.-P., Moretti, L., Paesmans, M., Remmelink, M., Richez, M., Roelandts, M., Scherpereel, A., Tulippe, C., Van Houtte, P., Sculier, J.-P., & European Lung Cancer Working Party, (2014). Les recommandations de pratique clinique de l'European Lung Cancer Working Party: Mises à jour. Revue médicale de Bruxelles, 35(3), 132-133.
  10. 22. Coleman, R., Aksnes, A. K., Naume, B., Garcia, C., Piccart-Gebhart, M., Flamen, P., Jerusalem, G., Vobecky, N., & Thuresson, M. (2014). A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease. Breast cancer research and treatment, 145(2), 411-418. doi:10.1007/s10549-014-2939-1
  11. 23. Gebhart, G., Gamez, C., Holmes, E., Robles Barba, J., Garcia, C., Cortés, M., de Azambuja, E., Fauria, K., van Dooren, V., Aktan, G., Coccia-Portugal, M., Kim, S.-B., Vuylsteke, P., Cure, H., Eidtmann, H., Baselga, J., Piccart-Gebhart, M., Flamen, P., & Di Cosimo, S. (2013). 18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO. The Journal of nuclear medicine, 54(11), 1862-1868. doi:10.2967/jnumed.112.119271
  12. 24. Hendlisz, A., Golfinopoulos, V., Deleporte, A., Paesmans, M., Mansy, H. E., Garcia, C., Peeters, M., Annemans, L., Vandeputte, C., Maetens, M. M., Borbath, I., Dresse, D., Houbiers, G., Fried, M., Awada, A., Piccart-Gebhart, M., Van Laethem, J.-L., & Flamen, P. (2013). Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC cancer, 13, 190. doi:10.1186/1471-2407-13-190
    13. << Précédent 1 2 3 4 Suivant >>